Vishal Shah
Child & Adolescent Psychiatry · Southlake, TXNPI 1588975312
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Neuronetics, Inc. at 31.9% of the total. Reporting peaked in 2024 at $901 and has fallen 85.0% since, to $135 in 2025.
Across 124 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$700
- AbbVie$307
- Supernus Pharmaceuticals, Inc.$256
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$209
- Corium, LLC$130
- Stryker$113
- plus $475 from 11 others
What the payments were for
- Food & beverage$2,190100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 25 | $700 |
| AbbVie | 28 | $307 |
| Supernus Pharmaceuticals, Inc. | 19 | $256 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $209 |
| Corium, LLC | 10 | $130 |
| Stryker | 5 | $113 |
| Neos Therapeutics, LP | 5 | $95 |
| Johnson & Johnson | 6 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Ironshore Pharmaceuticals Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Noven Therapeutics, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Biogen | 1 | $18 |
| Tris Pharma Inc | 1 | $17 |
| Livanova USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,190 in reported general payments places this provider in the 80th percentile of 301 child & adolescent psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atomoxetine Hcl | 19 | $2,401 |
| Methylphenidate Hcl | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Southlake
- Alain KaticBellaire$106K
- Steven PliszkaSan Antonio$59K
- Mary Garcia HolguinSan Antonio$24K
- John SteffekSpring$14K
- Robert MosquedaEdinburg$13K
- Gloria BrunGreenville$10K
- Mudassar TariqSugar Land$9K
- Charles PryzantDallas$9K
- Mehvesh AfrinaPlano$8K
- Kishore SunkaraHurst$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.